Nelfinavir, a Phase I/Phase II Rectal Cancer Study
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The aim is to study safety and activity of nelfinavir , added to standard chemoradiotherapy
in patients with locally advanced rectal cancer. Furthermore analysis of the effect of
nelfinavir combined with chemoradiation on tumour tissue will be studied